I can respond to that, Mr. Chair.
Although Quebec does not participate, it is affected by this situation. It waits for the federal review and, when Quebec makes a decision, it is influenced nonetheless. Sometimes the listing of a drug is called into question.
However, that was not my aim when I decided to present this motion. It was really because the millions of dollars come from Ottawa. Of the $20 million budgeted, $19 million is provided by the federal government to administer part of this organization. Thus, it is federal money.
Mr. Fletcher was just as active. When he was in opposition, Mr. Fletcher tabled a similar motion with regard to independent, not-for-profit corporations established by federal funding of endowment funds, which is the case with this organization.
Mr. Fletcher had tabled a motion to audit organizations such as Canada Health Infoway and Canadian Health Services Research Foundation, also an independent corporation. The characteristics were the same and, in one case, when Mr. Fletcher presented his motion, he voted in favour and the committee decided to vote—